The cancer medicine division of Siemens Healthineers is to revamp oncology in the Canadian province of Nova Scotia over the next ten years.

Varian has entered into a ten-year partnership with Nova Scotia Health, which is expected to bring the Erlangen-based medical technology group up to 175 million Canadian dollars (120 million euros), as Siemens Healthineers announced on Thursday. The aim is to accelerate the care of cancer patients "from screening to follow-up care and thus contribute to the improvement of Nova Scotia's healthcare system".

Cancer is more common than average among the province's one million inhabitants. Nova Scotia Health and Varian have been working together for over a year to build a "sustainable ecosystem" for cancer care, according to the press release. The collaboration will now be expanded. In return, Varian will open a branch with 60 employees in Halifax in the first half of the year and spend 50 million Canadian dollars on wages and rent over ten years.

Siemens Healthineers had already concluded similar agreements with other hospital groups and healthcare providers, albeit with a focus on imaging (MRI, CT).

(Report by Alexander Hübner, edited by Christian Götz. If you have any queries, please contact our editorial team at berlin.newsroom@thomsonreuters.com (for politics and the economy) or frankfurt.newsroom@thomsonreuters.com (for companies and markets).)